Table 2.
Univariate analysis of the management of the lesions in the follow-up
| Intervention group, n = 288 | CG, n = 87 | p value | |
|---|---|---|---|
| Lesion location, n (%) | |||
| Head/neck | 48 (17) | 43 (49) | <0.001 |
| Trunk | 177 (61) | 25 (29) | |
| Upper limb | 23 (8) | 10 (11) | |
| Lower limb | 40 (14) | 9 (10) | |
| Excision, n | 265 | 49 | <0.001 |
| Biopsy, n | 1 | 2 | 0.131 |
| Local treatment, n | 23 | 32 | <0.001 |
| Melanocytic lesions, n | |||
| Nevus | 186 | 10 | <0.001 |
| Dysplastic nevus | 137 | 2 | <0.001 |
| Malignant melanomas, n | 23 | 1 | 0.022 |
| Melanoma in situ | 14 | 1 | 0.208 |
| Invasive melanoma | 9 | 0 | 0.125 |
| Tumor thickness <1 mm | 9 | ||
| Stage IA | 8 | ||
| Stage IB | 1 | ||
| Actinic keratosis, n | 20 | 33 | <0.001 |
| BCC, n | 28 | 15 | 0.054 |
| Squamous cell carcinoma, n | 3 | 8 | <0.001 |